Role of the RANK/RANKL Pathway in Multiple Myeloma von Raje, Noopur S, Bhatta, Sumita, Terpos, Evangelos

Volltext

Panobinostat and Multiple Myeloma in 2018 von Yee, Andrew J., Raje, Noopur S.

Volltext

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial von Yee, Andrew J, MD, Bensinger, William I, MD, Supko, Jeffrey G, PhD, Voorhees, Peter M, MD, Berdeja, Jesus G, MD, Richardson, Paul G, Prof, Libby, Edward N, MD, Wallace, Ellen E, BA, Birrer, Nicole E, BA, Burke, Jill N, MSN, Tamang, David L, PhD, Yang, Min, PhD, Jones, Simon S, PhD, Wheeler, Catherine A, MD, Markelewicz, Robert J, MD, Raje, Noopur S, Dr

Volltext

A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma von O'Donnell, Elizabeth K., Laubach, Jacob P., Yee, Andrew J., Chen, Tianqi, Huff, Carol Ann, Basile, Frank G., Wade, Philip M., Paba‐Prada, Claudia E., Ghobrial, Irene M., Schlossman, Robert L., Burke, Jill N., Harrington, Cynthia C., Lively, Kathleen J., Lyons, Hannah F., Munshi, Nikhil C., Anderson, Kenneth C., Trippa, Lorenzo, Richardson, Paul G., Raje, Noopur S.

Volltext

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing von Guo, Guangwu, Raje, Noopur S., Seifer, Charles, Kloeber, Jake, Isenhart, Randi, Ha, Gavin, Yee, Andrew J., O’Donnell, Elizabeth K., Tai, Yu-Tzu, Richardson, Paul G., Bianchi, Giada, Laubach, Jacob P., Warren, Diane, Gemme, Erica, Voisine, Jordan, Frede, Julia, Kokkalis, Antonis, Yun, Huiyoung, Dimitrova, Valeriya, Vijaykumar, Tushara, Meyerson, Matthew, Munshi, Nikhil C., Anderson, Kenneth C., Knoechel, Birgit, Lohr, Jens G.

Volltext

The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo von Ikeda, Hiroshi, Hideshima, Teru, Fulciniti, Mariateresa, Lutz, Robert J, Yasui, Hiroshi, Okawa, Yutaka, Kiziltepe, Tanyel, Vallet, Sonia, Pozzi, Samantha, Santo, Loredana, Perrone, Giulia, Tai, Yu-Tzu, Cirstea, Diana, Raje, Noopur S, Uherek, Christoph, Dälken, Benjamin, Aigner, Silke, Osterroth, Frank, Munshi, Nikhil, Richardson, Paul, Anderson, Kenneth C

Volltext

Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee von Kumar, Shaji, Baizer, Lawrence, Callander, Natalie S., Giralt, Sergio A., Hillengass, Jens, Freidlin, Boris, Hoering, Antje, Richardson, Paul G., Schwartz, Elena I., Reiman, Anthony, Lentzsch, Suzanne, McCarthy, Philip L., Jagannath, Sundar, Yee, Andrew J., Little, Richard F., Raje, Noopur S.

Volltext

Lifestyle considerations in multiple myeloma von Shapiro, Yael N., Peppercorn, Jeffrey M., Yee, Andrew J., Branagan, Andrew R., Raje, Noopur S., Donnell, Elizabeth K. O’

Volltext

BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study von Kaley, Thomas, Touat, Mehdi, Subbiah, Vivek, Hollebecque, Antoine, Rodon, Jordi, Lockhart, A Craig, Keedy, Vicki, Bielle, Franck, Hofheinz, Ralf-Dieter, Joly, Florence, Blay, Jean-Yves, Chau, Ian, Puzanov, Igor, Raje, Noopur S, Wolf, Jurgen, DeAngelis, Lisa M, Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany, Baselga, Jose, Hyman, David M

Volltext

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations von Hyman, David M, Puzanov, Igor, Subbiah, Vivek, Faris, Jason E, Chau, Ian, Blay, Jean-Yves, Wolf, Jürgen, Raje, Noopur S, Diamond, Eli L, Hollebecque, Antoine, Gervais, Radj, Elez-Fernandez, Maria Elena, Italiano, Antoine, Hofheinz, Ralf-Dieter, Hidalgo, Manuel, Chan, Emily, Schuler, Martin, Lasserre, Susan Frances, Makrutzki, Martina, Sirzen, Florin, Veronese, Maria Luisa, Tabernero, Josep, Baselga, José

Volltext

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial von Bahlis, Nizar J., Costello, Caitlin L., Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael H., Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M., Trudel, Suzanne, Jakubowiak, Andrzej, Gasparetto, Cristina, Chu, Michael P., Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.

Volltext

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma von Richardson, Paul G., Weller, Edie, Lonial, Sagar, Jakubowiak, Andrzej J., Jagannath, Sundar, Raje, Noopur S., Avigan, David E., Xie, Wanling, Ghobrial, Irene M., Schlossman, Robert L., Mazumder, Amitabha, Munshi, Nikhil C., Vesole, David H., Joyce, Robin, Kaufman, Jonathan L., Doss, Deborah, Warren, Diane L., Lunde, Laura E., Kaster, Sarah, DeLaney, Carol, Hideshima, Teru, Mitsiades, Constantine S., Knight, Robert, Esseltine, Dixie-Lee, Anderson, Kenneth C.

Volltext

Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin von Dalva-Aydemir, Sevim, Bajpai, Richa, Martinez, Maylyn, Adekola, Kehinde U A, Kandela, Irawati, Wei, Changyong, Singhal, Seema, Koblinski, Jennifer E, Raje, Noopur S, Rosen, Steven T, Shanmugam, Mala

Volltext

Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma von Abramson, Jeremy S., Irwin, Kelly E., Frigault, Matthew J., Dietrich, Jorg, McGree, Brianne, Jordan, Justin T., Yee, Andrew J., Chen, Yi‐Bin, Raje, Noopur S., Barnes, Jeffrey A., Davis, Benjamin

Volltext

Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy von Ababneh, Hazim S., Yee, Andrew J., Raje, Noopur S., Martin, Sidney, Frigault, Matthew J., Ng, Andrea K., Patel, Chirayu G.

Volltext

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma von Richardson, Paul G., Xie, Wanling, Jagannath, Sundar, Jakubowiak, Andrzej, Lonial, Sagar, Raje, Noopur S., Alsina, Melissa, Ghobrial, Irene M., Schlossman, Robert L., Munshi, Nikhil C., Mazumder, Amitabha, Vesole, David H., Kaufman, Jonathan L., Colson, Kathleen, McKenney, Mary, Lunde, Laura E., Feather, John, Maglio, Michelle E., Warren, Diane, Francis, Dixil, Hideshima, Teru, Knight, Robert, Esseltine, Dixie-Lee, Mitsiades, Constantine S., Weller, Edie, Anderson, Kenneth C.

Volltext

Myeloma and Bone Disease von Panaroni, Cristina, Yee, Andrew J., Raje, Noopur S.

Volltext

Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma von Frede, Julia, Anand, Praveen, Sotudeh, Noori, Pinto, Ricardo A., Nair, Monica S., Stuart, Hannah, Yee, Andrew J., Vijaykumar, Tushara, Waldschmidt, Johannes M., Potdar, Sayalee, Kloeber, Jake A., Kokkalis, Antonis, Dimitrova, Valeriya, Mann, Mason, Laubach, Jacob P., Richardson, Paul G., Anderson, Kenneth C., Raje, Noopur S., Knoechel, Birgit, Lohr, Jens G.

Volltext

Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma von Waldschmidt, Johannes M., Kloeber, Jake A., Anand, Praveen, Frede, Julia, Kokkalis, Antonis, Dimitrova, Valeriya, Potdar, Sayalee, Nair, Monica S., Vijaykumar, Tushara, Im, Nam Gyu, Guillaumet-Adkins, Amy, Chopra, Nitish, Stuart, Hannah, Budano, Lillian, Sotudeh, Noori, Guo, Guangwu, Grassberger, Clemens, Yee, Andrew J., Laubach, Jacob P., Richardson, Paul G., Anderson, Kenneth C., Raje, Noopur S., Knoechel, Birgit, Lohr, Jens G.

Volltext

A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma von Laubach, Jacob P, Liu, Chia-Jen, Raje, Noopur S, Yee, Andrew J, Armand, Philippe, Schlossman, Robert L, Rosenblatt, Jacalyn, Hedlund, Jacquelyn, Martin, Michael, Reynolds, Craig, Shain, Kenneth H, Zackon, Ira, Stampleman, Laura, Henrick, Patrick, Rivotto, Bradley, Hornburg, Kalvis T V, Dumke, Henry J, Chuma, Stacey, Savell, Alexandra, Handisides, Damian R, Kroll, Stew, Anderson, Kenneth C, Richardson, Paul G, Ghobrial, Irene M

Volltext